Infectious Diseases Preliminary Screening Tests and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Infectious Diseases Preliminary Screening Tests Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Infectious Diseases Preliminary Screening Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Infectious Diseases Preliminary Screening Tests Overall Market Size
2.1 Global Infectious Diseases Preliminary Screening Tests Market Size: 2024 VS 2032
2.2 Global Infectious Diseases Preliminary Screening Tests Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Infectious Diseases Preliminary Screening Tests Sales: 2020-2032
3 Company Landscape
3.1 Top Infectious Diseases Preliminary Screening Tests Players in Global Market
3.2 Top Global Infectious Diseases Preliminary Screening Tests Companies Ranked by Revenue
3.3 Global Infectious Diseases Preliminary Screening Tests Revenue by Companies
3.4 Global Infectious Diseases Preliminary Screening Tests Sales by Companies
3.5 Global Infectious Diseases Preliminary Screening Tests Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Infectious Diseases Preliminary Screening Tests Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Infectious Diseases Preliminary Screening Tests Product Type
3.8 Tier 1, Tier 2, and Tier 3 Infectious Diseases Preliminary Screening Tests Players in Global Market
3.8.1 List of Global Tier 1 Infectious Diseases Preliminary Screening Tests Companies
3.8.2 List of Global Tier 2 and Tier 3 Infectious Diseases Preliminary Screening Tests Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Infectious Diseases Preliminary Screening Tests Market Size Markets, 2024 & 2032
4.1.2 Over-the-Counter Rapid Test Product
4.1.3 Professional Rapid Test Product
4.2 Segment by Type - Global Infectious Diseases Preliminary Screening Tests Revenue & Forecasts
4.2.1 Segment by Type - Global Infectious Diseases Preliminary Screening Tests Revenue, 2020-2025
4.2.2 Segment by Type - Global Infectious Diseases Preliminary Screening Tests Revenue, 2026-2032
4.2.3 Segment by Type - Global Infectious Diseases Preliminary Screening Tests Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Infectious Diseases Preliminary Screening Tests Sales & Forecasts
4.3.1 Segment by Type - Global Infectious Diseases Preliminary Screening Tests Sales, 2020-2025
4.3.2 Segment by Type - Global Infectious Diseases Preliminary Screening Tests Sales, 2026-2032
4.3.3 Segment by Type - Global Infectious Diseases Preliminary Screening Tests Sales Market Share, 2020-2032
4.4 Segment by Type - Global Infectious Diseases Preliminary Screening Tests Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Infectious Diseases Preliminary Screening Tests Market Size, 2024 & 2032
5.1.2 Infectious Diseases
5.1.3 Hepatitis
5.1.4 Influenza
5.1.5 Malaria
5.1.6 HIV
5.1.7 Other
5.2 Segment by Application - Global Infectious Diseases Preliminary Screening Tests Revenue & Forecasts
5.2.1 Segment by Application - Global Infectious Diseases Preliminary Screening Tests Revenue, 2020-2025
5.2.2 Segment by Application - Global Infectious Diseases Preliminary Screening Tests Revenue, 2026-2032
5.2.3 Segment by Application - Global Infectious Diseases Preliminary Screening Tests Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Infectious Diseases Preliminary Screening Tests Sales & Forecasts
5.3.1 Segment by Application - Global Infectious Diseases Preliminary Screening Tests Sales, 2020-2025
5.3.2 Segment by Application - Global Infectious Diseases Preliminary Screening Tests Sales, 2026-2032
5.3.3 Segment by Application - Global Infectious Diseases Preliminary Screening Tests Sales Market Share, 2020-2032
5.4 Segment by Application - Global Infectious Diseases Preliminary Screening Tests Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Infectious Diseases Preliminary Screening Tests Market Size, 2024 & 2032
6.2 By Region - Global Infectious Diseases Preliminary Screening Tests Revenue & Forecasts
6.2.1 By Region - Global Infectious Diseases Preliminary Screening Tests Revenue, 2020-2025
6.2.2 By Region - Global Infectious Diseases Preliminary Screening Tests Revenue, 2026-2032
6.2.3 By Region - Global Infectious Diseases Preliminary Screening Tests Revenue Market Share, 2020-2032
6.3 By Region - Global Infectious Diseases Preliminary Screening Tests Sales & Forecasts
6.3.1 By Region - Global Infectious Diseases Preliminary Screening Tests Sales, 2020-2025
6.3.2 By Region - Global Infectious Diseases Preliminary Screening Tests Sales, 2026-2032
6.3.3 By Region - Global Infectious Diseases Preliminary Screening Tests Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Infectious Diseases Preliminary Screening Tests Revenue, 2020-2032
6.4.2 By Country - North America Infectious Diseases Preliminary Screening Tests Sales, 2020-2032
6.4.3 United States Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.4.4 Canada Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.4.5 Mexico Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Infectious Diseases Preliminary Screening Tests Revenue, 2020-2032
6.5.2 By Country - Europe Infectious Diseases Preliminary Screening Tests Sales, 2020-2032
6.5.3 Germany Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.5.4 France Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.5.5 U.K. Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.5.6 Italy Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.5.7 Russia Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.5.8 Nordic Countries Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.5.9 Benelux Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Infectious Diseases Preliminary Screening Tests Revenue, 2020-2032
6.6.2 By Region - Asia Infectious Diseases Preliminary Screening Tests Sales, 2020-2032
6.6.3 China Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.6.4 Japan Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.6.5 South Korea Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.6.6 Southeast Asia Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.6.7 India Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Infectious Diseases Preliminary Screening Tests Revenue, 2020-2032
6.7.2 By Country - South America Infectious Diseases Preliminary Screening Tests Sales, 2020-2032
6.7.3 Brazil Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.7.4 Argentina Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Infectious Diseases Preliminary Screening Tests Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Infectious Diseases Preliminary Screening Tests Sales, 2020-2032
6.8.3 Turkey Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.8.4 Israel Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.8.5 Saudi Arabia Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
6.8.6 UAE Infectious Diseases Preliminary Screening Tests Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.1.4 Abbott Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.1.5 Abbott Key News & Latest Developments
7.2 BD
7.2.1 BD Company Summary
7.2.2 BD Business Overview
7.2.3 BD Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.2.4 BD Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.2.5 BD Key News & Latest Developments
7.3 Bio-rad Laboratories, Inc
7.3.1 Bio-rad Laboratories, Inc Company Summary
7.3.2 Bio-rad Laboratories, Inc Business Overview
7.3.3 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.3.4 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.3.5 Bio-rad Laboratories, Inc Key News & Latest Developments
7.4 Cepheid
7.4.1 Cepheid Company Summary
7.4.2 Cepheid Business Overview
7.4.3 Cepheid Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.4.4 Cepheid Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.4.5 Cepheid Key News & Latest Developments
7.5 Hologic Inc
7.5.1 Hologic Inc Company Summary
7.5.2 Hologic Inc Business Overview
7.5.3 Hologic Inc Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.5.4 Hologic Inc Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.5.5 Hologic Inc Key News & Latest Developments
7.6 Meridian Bioscience, Inc
7.6.1 Meridian Bioscience, Inc Company Summary
7.6.2 Meridian Bioscience, Inc Business Overview
7.6.3 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.6.4 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.6.5 Meridian Bioscience, Inc Key News & Latest Developments
7.7 OraSure Technologies, Inc
7.7.1 OraSure Technologies, Inc Company Summary
7.7.2 OraSure Technologies, Inc Business Overview
7.7.3 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.7.4 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.7.5 OraSure Technologies, Inc Key News & Latest Developments
7.8 Quidel Corporation
7.8.1 Quidel Corporation Company Summary
7.8.2 Quidel Corporation Business Overview
7.8.3 Quidel Corporation Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.8.4 Quidel Corporation Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.8.5 Quidel Corporation Key News & Latest Developments
7.9 F. Hoffmann-La Roche Ltd
7.9.1 F. Hoffmann-La Roche Ltd Company Summary
7.9.2 F. Hoffmann-La Roche Ltd Business Overview
7.9.3 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.9.4 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.9.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.10 BUREAU VERITAS
7.10.1 BUREAU VERITAS Company Summary
7.10.2 BUREAU VERITAS Business Overview
7.10.3 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.10.4 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.10.5 BUREAU VERITAS Key News & Latest Developments
7.11 Eurofins Scientific
7.11.1 Eurofins Scientific Company Summary
7.11.2 Eurofins Scientific Business Overview
7.11.3 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.11.4 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.11.5 Eurofins Scientific Key News & Latest Developments
7.12 Siemens Healthcare Private Limited
7.12.1 Siemens Healthcare Private Limited Company Summary
7.12.2 Siemens Healthcare Private Limited Business Overview
7.12.3 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.12.4 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.12.5 Siemens Healthcare Private Limited Key News & Latest Developments
7.13 Luminex Corporation
7.13.1 Luminex Corporation Company Summary
7.13.2 Luminex Corporation Business Overview
7.13.3 Luminex Corporation Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.13.4 Luminex Corporation Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.13.5 Luminex Corporation Key News & Latest Developments
7.14 PerkinElmer Inc
7.14.1 PerkinElmer Inc Company Summary
7.14.2 PerkinElmer Inc Business Overview
7.14.3 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.14.4 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.14.5 PerkinElmer Inc Key News & Latest Developments
7.15 QIAGEN
7.15.1 QIAGEN Company Summary
7.15.2 QIAGEN Business Overview
7.15.3 QIAGEN Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.15.4 QIAGEN Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.15.5 QIAGEN Key News & Latest Developments
7.16 Mesa Biotech
7.16.1 Mesa Biotech Company Summary
7.16.2 Mesa Biotech Business Overview
7.16.3 Mesa Biotech Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.16.4 Mesa Biotech Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.16.5 Mesa Biotech Key News & Latest Developments
7.17 Illumina, Inc
7.17.1 Illumina, Inc Company Summary
7.17.2 Illumina, Inc Business Overview
7.17.3 Illumina, Inc Infectious Diseases Preliminary Screening Tests Major Product Offerings
7.17.4 Illumina, Inc Infectious Diseases Preliminary Screening Tests Sales and Revenue in Global (2020-2025)
7.17.5 Illumina, Inc Key News & Latest Developments
8 Global Infectious Diseases Preliminary Screening Tests Production Capacity, Analysis
8.1 Global Infectious Diseases Preliminary Screening Tests Production Capacity, 2020-2032
8.2 Infectious Diseases Preliminary Screening Tests Production Capacity of Key Manufacturers in Global Market
8.3 Global Infectious Diseases Preliminary Screening Tests Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Infectious Diseases Preliminary Screening Tests Supply Chain Analysis
10.1 Infectious Diseases Preliminary Screening Tests Industry Value Chain
10.2 Infectious Diseases Preliminary Screening Tests Upstream Market
10.3 Infectious Diseases Preliminary Screening Tests Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Infectious Diseases Preliminary Screening Tests Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Infectious Diseases Preliminary Screening Tests in Global Market
Table 2. Top Infectious Diseases Preliminary Screening Tests Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Infectious Diseases Preliminary Screening Tests Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Infectious Diseases Preliminary Screening Tests Revenue Share by Companies, 2020-2025
Table 5. Global Infectious Diseases Preliminary Screening Tests Sales by Companies, (K Units), 2020-2025
Table 6. Global Infectious Diseases Preliminary Screening Tests Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Infectious Diseases Preliminary Screening Tests Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Infectious Diseases Preliminary Screening Tests Product Type
Table 9. List of Global Tier 1 Infectious Diseases Preliminary Screening Tests Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Diseases Preliminary Screening Tests Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Infectious Diseases Preliminary Screening Tests Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Infectious Diseases Preliminary Screening Tests Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Infectious Diseases Preliminary Screening Tests Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Infectious Diseases Preliminary Screening Tests Sales (K Units), 2026-2032
Table 16. Segment by Application � Global Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2026-2032
Table 21. By Region � Global Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2020-2025
Table 25. By Region - Global Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2026-2032
Table 26. By Country - North America Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2020-2025
Table 29. By Country - North America Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2026-2032
Table 30. By Country - Europe Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2020-2025
Table 33. By Country - Europe Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2026-2032
Table 34. By Region - Asia Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2020-2025
Table 37. By Region - Asia Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2026-2032
Table 38. By Country - South America Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2020-2025
Table 41. By Country - South America Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2026-2032
Table 42. By Country - Middle East & Africa Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Infectious Diseases Preliminary Screening Tests Sales, (K Units), 2026-2032
Table 46. Abbott Company Summary
Table 47. Abbott Infectious Diseases Preliminary Screening Tests Product Offerings
Table 48. Abbott Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Abbott Key News & Latest Developments
Table 50. BD Company Summary
Table 51. BD Infectious Diseases Preliminary Screening Tests Product Offerings
Table 52. BD Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. BD Key News & Latest Developments
Table 54. Bio-rad Laboratories, Inc Company Summary
Table 55. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product Offerings
Table 56. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Bio-rad Laboratories, Inc Key News & Latest Developments
Table 58. Cepheid Company Summary
Table 59. Cepheid Infectious Diseases Preliminary Screening Tests Product Offerings
Table 60. Cepheid Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Cepheid Key News & Latest Developments
Table 62. Hologic Inc Company Summary
Table 63. Hologic Inc Infectious Diseases Preliminary Screening Tests Product Offerings
Table 64. Hologic Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Hologic Inc Key News & Latest Developments
Table 66. Meridian Bioscience, Inc Company Summary
Table 67. Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product Offerings
Table 68. Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Meridian Bioscience, Inc Key News & Latest Developments
Table 70. OraSure Technologies, Inc Company Summary
Table 71. OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product Offerings
Table 72. OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. OraSure Technologies, Inc Key News & Latest Developments
Table 74. Quidel Corporation Company Summary
Table 75. Quidel Corporation Infectious Diseases Preliminary Screening Tests Product Offerings
Table 76. Quidel Corporation Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Quidel Corporation Key News & Latest Developments
Table 78. F. Hoffmann-La Roche Ltd Company Summary
Table 79. F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product Offerings
Table 80. F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 82. BUREAU VERITAS Company Summary
Table 83. BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product Offerings
Table 84. BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. BUREAU VERITAS Key News & Latest Developments
Table 86. Eurofins Scientific Company Summary
Table 87. Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product Offerings
Table 88. Eurofins Scientific Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Eurofins Scientific Key News & Latest Developments
Table 90. Siemens Healthcare Private Limited Company Summary
Table 91. Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product Offerings
Table 92. Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Siemens Healthcare Private Limited Key News & Latest Developments
Table 94. Luminex Corporation Company Summary
Table 95. Luminex Corporation Infectious Diseases Preliminary Screening Tests Product Offerings
Table 96. Luminex Corporation Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Luminex Corporation Key News & Latest Developments
Table 98. PerkinElmer Inc Company Summary
Table 99. PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product Offerings
Table 100. PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. PerkinElmer Inc Key News & Latest Developments
Table 102. QIAGEN Company Summary
Table 103. QIAGEN Infectious Diseases Preliminary Screening Tests Product Offerings
Table 104. QIAGEN Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. QIAGEN Key News & Latest Developments
Table 106. Mesa Biotech Company Summary
Table 107. Mesa Biotech Infectious Diseases Preliminary Screening Tests Product Offerings
Table 108. Mesa Biotech Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 109. Mesa Biotech Key News & Latest Developments
Table 110. Illumina, Inc Company Summary
Table 111. Illumina, Inc Infectious Diseases Preliminary Screening Tests Product Offerings
Table 112. Illumina, Inc Infectious Diseases Preliminary Screening Tests Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 113. Illumina, Inc Key News & Latest Developments
Table 114. Infectious Diseases Preliminary Screening Tests Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 115. Global Infectious Diseases Preliminary Screening Tests Capacity Market Share of Key Manufacturers, 2023-2025
Table 116. Global Infectious Diseases Preliminary Screening Tests Production by Region, 2020-2025 (K Units)
Table 117. Global Infectious Diseases Preliminary Screening Tests Production by Region, 2026-2032 (K Units)
Table 118. Infectious Diseases Preliminary Screening Tests Market Opportunities & Trends in Global Market
Table 119. Infectious Diseases Preliminary Screening Tests Market Drivers in Global Market
Table 120. Infectious Diseases Preliminary Screening Tests Market Restraints in Global Market
Table 121. Infectious Diseases Preliminary Screening Tests Raw Materials
Table 122. Infectious Diseases Preliminary Screening Tests Raw Materials Suppliers in Global Market
Table 123. Typical Infectious Diseases Preliminary Screening Tests Downstream
Table 124. Infectious Diseases Preliminary Screening Tests Downstream Clients in Global Market
Table 125. Infectious Diseases Preliminary Screening Tests Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Infectious Diseases Preliminary Screening Tests Product Picture
Figure 2. Infectious Diseases Preliminary Screening Tests Segment by Type in 2024
Figure 3. Infectious Diseases Preliminary Screening Tests Segment by Application in 2024
Figure 4. Global Infectious Diseases Preliminary Screening Tests Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Infectious Diseases Preliminary Screening Tests Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Infectious Diseases Preliminary Screening Tests Revenue: 2020-2032 (US$, Mn)
Figure 8. Infectious Diseases Preliminary Screening Tests Sales in Global Market: 2020-2032 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Infectious Diseases Preliminary Screening Tests Revenue in 2024
Figure 10. Segment by Type � Global Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Infectious Diseases Preliminary Screening Tests Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Infectious Diseases Preliminary Screening Tests Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Infectious Diseases Preliminary Screening Tests Price (US$/Unit), 2020-2032
Figure 14. Segment by Application � Global Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Infectious Diseases Preliminary Screening Tests Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Infectious Diseases Preliminary Screening Tests Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Infectious Diseases Preliminary Screening Tests Price (US$/Unit), 2020-2032
Figure 18. By Region � Global Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Infectious Diseases Preliminary Screening Tests Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Infectious Diseases Preliminary Screening Tests Revenue Market Share, 2020-2032
Figure 21. By Region - Global Infectious Diseases Preliminary Screening Tests Sales Market Share, 2020-2032
Figure 22. By Country - North America Infectious Diseases Preliminary Screening Tests Revenue Market Share, 2020-2032
Figure 23. By Country - North America Infectious Diseases Preliminary Screening Tests Sales Market Share, 2020-2032
Figure 24. United States Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Infectious Diseases Preliminary Screening Tests Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Infectious Diseases Preliminary Screening Tests Sales Market Share, 2020-2032
Figure 29. Germany Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 30. France Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Infectious Diseases Preliminary Screening Tests Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Infectious Diseases Preliminary Screening Tests Sales Market Share, 2020-2032
Figure 38. China Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 42. India Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Infectious Diseases Preliminary Screening Tests Revenue Market Share, 2020-2032
Figure 44. By Country - South America Infectious Diseases Preliminary Screening Tests Sales, Market Share, 2020-2032
Figure 45. Brazil Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Infectious Diseases Preliminary Screening Tests Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Infectious Diseases Preliminary Screening Tests Sales, Market Share, 2020-2032
Figure 49. Turkey Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Infectious Diseases Preliminary Screening Tests Revenue, (US$, Mn), 2020-2032
Figure 53. Global Infectious Diseases Preliminary Screening Tests Production Capacity (K Units), 2020-2032
Figure 54. The Percentage of Production Infectious Diseases Preliminary Screening Tests by Region, 2024 VS 2032
Figure 55. Infectious Diseases Preliminary Screening Tests Industry Value Chain
Figure 56. Marketing Channels
